---
company: Avalo Therapeutics, Inc.
ticker: AVTX
form: 8-K
filed: 2026-05-07
accession: 0001104659-26-056482
source: https://www.sec.gov/Archives/edgar/data/1534120/000110465926056482/
---

# Avalo Therapeutics (AVTX) earnings release, May 7, 2026

Avalo Therapeutics, Inc. (AVTX) · Form 8-K, Item 2.02 · Filed 2026-05-07 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1534120/000110465926056482/)

No press release attached to this 8-K.
